Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Delin Ventures is a mission-driven venture capital firm founded to support advancements in life sciences and technology. The firm is dedicated to partnering with entrepreneurs and scientists to leverage breakthrough technologies that aim to transform lives. Although specific fund sizes and portfolio counts are not disclosed, Delin Ventures operates two primary funds: the Life Sciences Fund and the Technology Fund. The Life Sciences Fund focuses on building scalable and commercially sustainable cell therapy companies, while the Technology Fund invests in early-stage technology companies, providing support akin to that of super-angels. Founded with a vision to create long-term impact, Delin Ventures emphasizes patient capital, aiming to enhance the success of its portfolio companies through operational expertise and a robust network of experts and investors. The firm is recognized for its commitment to fostering innovation in sectors that have the potential to significantly improve health outcomes and technological advancements.
Delin Ventures has a clear investment focus on life sciences and technology, specifically targeting sectors such as biotech, healthcare, artificial intelligence (AI), and software as a service (SaaS). The firm operates two distinct funds: the Life Sciences Fund, which is dedicated to investing in and building cell therapy companies, and the Technology Fund, which focuses on early-stage technology ventures. Delin Ventures seeks to invest at various stages, including pre-seed, seed, seed-plus, and Series A, allowing them to engage with companies at critical points in their development. The firm emphasizes scalability and commercial sustainability in its investments, particularly within the life sciences sector. By providing operational expertise and leveraging a strong network of industry experts and investors, Delin Ventures aims to enhance the success of its portfolio companies. This approach not only supports the growth of innovative solutions but also aligns with their mission to create a lasting impact in the fields they invest in.
Delin Ventures invests at various stages, including pre-seed, seed, seed-plus, and Series A. This diverse stage focus allows them to engage with startups at critical points in their development.
The firm primarily focuses on life sciences, including biotech and healthcare, as well as technology sectors such as artificial intelligence (AI) and software as a service (SaaS). This dual focus enables them to support a wide range of innovative companies.
While specific check sizes are not disclosed, Delin Ventures operates with a super-angel approach in their Technology Fund, suggesting they provide substantial early-stage funding to support startups.
Delin Ventures does not specify a geographic focus in the provided information, indicating that they may consider investments in various locations, particularly where innovative life sciences and technology companies are emerging.
The application process details are not provided in the source material. However, interested founders should prepare a compelling pitch that aligns with Delin Ventures' focus on life sciences and technology.
Delin Ventures emphasizes operational expertise and a strong network to support its portfolio companies. This approach aims to enhance the success of their investments through strategic guidance and connections within the industry.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.